title: [Research into new methods for diagnosing, treating and preventing tuberculosis].
abstract: Tuberculosis control requires improved diagnostics, drugs, and vaccines. Their development is facilitated by progress in immunology, molecular biology, and genomics. In addition to sputum smear and culture, amplification techniques can already be used to diagnose tuberculosis and antigen-detection tests for this purpose are being developed. Molecular typing and DNA microarrays provide new insights in the natural history and transmission of tuberculosis. In addition to established drugs such as rifampicin, isoniazid, pyrazinamide, and ethambutol, a limited number of new drugs have been discovered such as rifampicin derivates and fluorochinolones. Improved screening techniques and insights from genomics may lead to new drugs being discovered. Factors hampering the development and evaluation of new vaccines include problems with extrapolation from animal models, incomplete natural immunity, and limited knowledge about protective immunity. However, new candidate vaccines are being developed and will be tested on humans in the near future.
authors.affiliation: Academisch Medisch Centrum/Universiteit van Amsterdam, Amsterdam. borgdorffm@kncvtbc.nl
authors.forename: M W
authors.initials: MW
authors.lastname: Borgdorff
authors.forename: A
authors.initials: A
authors.lastname: Kolk
authors.forename: D
authors.initials: D
authors.lastname: van Soolingen
authors.forename: J W
authors.initials: JW
authors.lastname: van der Meer
authors.forename: T H
authors.initials: TH
authors.lastname: Ottenhoff
mesh_terms: D000818:Animals; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D004338:Drug Combinations; D023281:Genomics; D006801:Humans; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D032581:Tuberculosis Vaccines
chemical_list: D000904:Antibiotics, Antitubercular; D004338:Drug Combinations; D032581:Tuberculosis Vaccines